Ongeveer 20 uur geleden - Universiteit van Amsterdam (UvA) - Amsterdam
The Van't Hoff Institute for Molecular Sciences (HIMS) and the Institute of Physics (IoP) of the Faculty of Science invite applications for a four-year …
Hearing loss is the most prevalent sensory disorder and affects about 1 in 1,000 newborns. Genetic causes are estimated to cause about half of the congenital …
Hearing loss is the most prevalent sensory disorder and affects about 1 in 1,000 newborns. Genetic causes are estimated to cause about half of the congenital hearing loss. Hearing loss can be rehabilitated by hearing aids or implantable hearing devices but a cure is currently not available. However, recently many start-up companies have emerged to work on the development of inner ear therapies treating hearing loss and tinnitus with hair cell regeneration, stem cell therapy, genetic therapy or other molecular inner ear therapies. Hearing & Genes, a collaboration of the Ear-Nose-Throat and Genetics Departments of the Radboud university medical center, wants to evaluate these novel molecular therapies by performing clinical trials in close collaboration with these companies and the Radboud Technology Center for Clinical Studies.
A highly motivated postdoc is searched to recruit and organise clinical trials to treat inner ear disorders and to perform natural history studies that evaluate progression of hereditary hearing loss and deafblindness. The postdoc will also be involved in the supervision of PhD students and is expected to write grant proposals. After three years, the postdoc has to be able to sustain his/her position with obtained grants. Experience with the organisation of trials, writing grant proposals and supervision of PhD students is a bonus.
Tasks and responsibilities
We are looking for an enthusiastic postdoc with a PhD in clinical epidemiology who is eager to work in a highly motivated team of researchers who want to cure hearing loss by bringing inner ear molecular therapies via clinical trials into society.